These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 31277584)
1. Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing. Lokhandwala PM; Tseng LH; Rodriguez E; Zheng G; Pallavajjalla A; Gocke CD; Eshleman JR; Lin MT BMC Cancer; 2019 Jul; 19(1):665. PubMed ID: 31277584 [TBL] [Abstract][Full Text] [Related]
2. Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia. Bezić J; Tomić I; Pavić M Acta Dermatovenerol Croat; 2024 Mar; 32(1):75-76. PubMed ID: 38946192 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma. Yaman B; Akalin T; Kandiloğlu G Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015 [TBL] [Abstract][Full Text] [Related]
4. [ Spectrum of oncogene mutations is different in melanoma subtypes]. Mazurenko NN; Tsyganova IV; Lushnikova AA; Ponkratova DA; Anurova OA; Cheremushkin EA; Mikhailova IN; Demidov LV Mol Biol (Mosk); 2015; 49(6):1022-9. PubMed ID: 26710785 [TBL] [Abstract][Full Text] [Related]
5. Clinical validation of coexisting driver mutations in colorectal cancers. Zheng G; Tseng LH; Haley L; Ibrahim J; Bynum J; Xian R; Gocke CD; Eshleman JR; Lin MT Hum Pathol; 2019 Apr; 86():12-20. PubMed ID: 30481508 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients. Sakaizawa K; Ashida A; Uchiyama A; Ito T; Fujisawa Y; Ogata D; Matsushita S; Fujii K; Fukushima S; Shibayama Y; Hatta N; Takenouchi T; Uehara J; Okuyama R; Yamazaki N; Uhara H J Dermatol Sci; 2015 Oct; 80(1):33-7. PubMed ID: 26282084 [TBL] [Abstract][Full Text] [Related]
7. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation]. Lázár V Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354 [TBL] [Abstract][Full Text] [Related]
8. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands. van Engen-van Grunsven AC; Küsters-Vandevelde HV; De Hullu J; van Duijn LM; Rijntjes J; Bovée JV; Groenen PJ; Blokx WA Gynecol Oncol; 2014 Jul; 134(1):10-4. PubMed ID: 24802725 [TBL] [Abstract][Full Text] [Related]
9. The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort. Ekedahl H; Cirenajwis H; Harbst K; Carneiro A; Nielsen K; Olsson H; Lundgren L; Ingvar C; Jönsson G Br J Dermatol; 2013 Nov; 169(5):1049-55. PubMed ID: 23855428 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma. Moltara ME; Novakovic S; Boc M; Bucic M; Rebersek M; Zadnik V; Ocvirk J Radiol Oncol; 2018 Apr; 52(3):289-295. PubMed ID: 30210039 [TBL] [Abstract][Full Text] [Related]
11. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma. Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143 [TBL] [Abstract][Full Text] [Related]
12. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma. Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K; JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664 [TBL] [Abstract][Full Text] [Related]
13. Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis. Jahn SW; Kashofer K; Halbwedl I; Winter G; El-Shabrawi-Caelen L; Mentzel T; Hoefler G; Liegl-Atzwanger B Mod Pathol; 2015 Jul; 28(7):895-903. PubMed ID: 25769001 [TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers. Haley L; Tseng LH; Zheng G; Dudley J; Anderson DA; Azad NS; Gocke CD; Eshleman JR; Lin MT Mod Pathol; 2015 Oct; 28(10):1390-9. PubMed ID: 26226847 [TBL] [Abstract][Full Text] [Related]
15. Clinical detection and categorization of uncommon and concomitant mutations involving BRAF. Zheng G; Tseng LH; Chen G; Haley L; Illei P; Gocke CD; Eshleman JR; Lin MT BMC Cancer; 2015 Oct; 15():779. PubMed ID: 26498038 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma. Barel F; Guibourg B; Lambros L; Le Flahec G; Marcorelles P; Uguen A Acta Derm Venereol; 2018 Jan; 98(1):44-49. PubMed ID: 28660280 [TBL] [Abstract][Full Text] [Related]
17. Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations. Tsushima N; Kano S; Hatanaka KC; Suzuki T; Hamada S; Idogawa H; Nakamaru Y; Suzuki M; Hatanaka Y; Homma A Auris Nasus Larynx; 2024 Apr; 51(2):313-319. PubMed ID: 37953090 [TBL] [Abstract][Full Text] [Related]
18. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage. Mar VJ; Wong SQ; Li J; Scolyer RA; McLean C; Papenfuss AT; Tothill RW; Kakavand H; Mann GJ; Thompson JF; Behren A; Cebon JS; Wolfe R; Kelly JW; Dobrovic A; McArthur GA Clin Cancer Res; 2013 Sep; 19(17):4589-98. PubMed ID: 23833303 [TBL] [Abstract][Full Text] [Related]
19. BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis. Min KW; Choe JY; Kwon MJ; Lee HK; Kang HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Kim YJ; Kim NY; Kim HY Pathol Res Pract; 2019 Dec; 215(12):152671. PubMed ID: 31630873 [TBL] [Abstract][Full Text] [Related]
20. Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals. Gao HW; Tsai WC; Perng CL; Wang WM; Chiang CP Eur J Dermatol; 2018 Aug; 28(4):509-518. PubMed ID: 30325319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]